Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
WuXi AppTech has officially opened its...
WuXi PharmaTech, a CRO known mostly for...
WuXi PharmaTech is forming a JV with...
WuXi PharmaTech signed a second...
WuXi PharmaTech reported another year of...
Syros Pharmaceuticals, a Boston area startup, raised $30...
Syros Pharmaceuticals of Boston raised $30 million to...
ChinaBio® recently had a chance to talk with Richard...
WuXi PharmaTech released positive...
Zhejiang Medicine Co. formed a collaboration with Ambrx...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China